Official Journal of Research Center for Gastroenterology and Liver Diseases
OpenCitations
Works that cite this article, indexed by OpenCitations.
Comparison of prevention, screening and treatment of hepatitis C in Iran, Egypt and Georgia
Journal of Virus Eradication 5(2) (2019)
Masoud Behzadifar; Hasan Abolghasem Gorji; Aziz Rezapour; Nicola Luigi Bragazzi
New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years
World Journal of Gastroenterology 27(29) (2021)
Brittany B Dennis; Leen Naji; Yasmin Jajarmi; Aijaz Ahmed; Donghee Kim
Chronic Hepatitis C: Do Generics Work as Well as Branded Drugs?
Journal of Clinical and Experimental Hepatology 7(3) (2017)
Madhumita Premkumar; Gagandeep S. Grover; Radha K. Dhiman
An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam study
International Journal of Drug Policy 102 (2022)
Ali Mirzazadeh; Samira Hosseini-Hooshyar; Armita Shahesmaeili; Heidar Sharafi; Mohammad Shafiei; Jasem Zarei; Ghazal Mousavian; Fatemeh Tavakoli; Nima Ghalekhani; Mostafa Shokoohi; Mehrdad Khezri; Soheil Mehmandoost; Mohammad Reza Shojaei; Mohammad Karamouzian; Alya Briceno; Meghan D. Morris; Seyed Moayed Alavian; Ali-Akbar Haghdoost; Hamid Sharifi; Kimberly A. Page
An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE study
International Journal of Drug Policy 72 (2019)
Maryam Alavi; Hossein Poustchi; Shahin Merat; Soudeh Kaveh-ei; Afarin Rahimi-Movaghar; Behrang Shadloo; Behzad Hajarizadeh; Jason Grebely; Gregory J. Dore; Reza Malekzadeh
Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study
BMJ Open 12(6) (2022)
Mohammad Tasavon Gholamhoseini; Heidar Sharafi; Helena HL Borba; Seyed Moayed Alavian; Asma Sabermahani; Behzad Hajarizadeh
Methadone Maintenance Therapy (MMT) Clients Should Be More Noticed for Hepatitis C Elimination in Iran
Thrita 6(2) (2017)
Hamidreza Karimi-Sari; Seyed Moayed Alavian
Response of Daclatasvir and Sofosbuvir in Treatment-Naïve, HCV Genotype 3, Non-Cirrhotic Pakistani Population: 1 Year Follow-Up Experience
Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical University 19(2) (2023)
Nadeem Islam; Shirin Aamir; Aleena Hussain Rana; Syed Mohsin Naveed; Mujeeb Ur Rehman
Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting
Journal of Hepatology 71(6) (2019)
Radha K. Dhiman; Gagandeep S. Grover; Madhumita Premkumar; Sunil Taneja; Ajay Duseja; Sanjeev Arora; Sahaj Rathi; Sandeep Satsangi; Akash Roy
Direct‐acting antiviral agents in the treatment of chronic hepatitis C—Real‐life experience from clinical practices in Pakistan
Journal of Medical Virology 92(12) (2020)
Saima Mushtaq; Atika Mansoor; Muhammad Umar; Amjad Khan; Saima Siddiqi; Sobia Manzoor
Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges
Gastroenterology 156(2) (2019)
Thomas F. Baumert; Thomas Berg; Joseph K. Lim; David R. Nelson